The American Association for the Study of Liver Diseases (AASLD) [5] and European Association for the Study of the Liver (EASL) [6] recommend ultrasound and alpha-fetoprotein (AFP) tests to high-risk populations including patients with cirrhosis and non-cirrhotic chronic hepatitis B (CHB) as screening strategies for liver cancer. The gene discussed is AFP; the disease is liver disorder.